National Health Service Corps Loan Repayment - 340B Drug Pricing Program

View in your browser

National Health Service Corps Loan Repayment: Apply by March 20

If you are a licensed primary care medical, dental or mental/behavioral health clinician in an eligible discipline and have a job (or an employment contract by July 15, 2014) at a National Health Service Corps-approved site, you may be eligible to apply for help paying your unpaid qualifying education loans.

Offering both full- and part-time options, the NHSC loan repayment program provides as much as $50,000 (exempt from Federal income and employment taxes) for an initial 2-year, full-time service commitment, with the opportunity to apply for additional loan repayment assistance for extended service.

The NHSC seeks clinicians committed to serving the nation’s medically underserved populations to fulfill the program’s primary purpose: to increase access to primary care services for communities in need.

For complete information on the program and the application process, visit National Health Service Corps Loan Repayment Program.

 


 

Funding Opportunities

HRSA-14-072  Nurse Faculty Loan Program (NFLP)
Apply at Grants.gov by February 03

HRSA-14-098  Ryan White HIV/AIDS Program Part F Dental Reimbursement Program (DRP)
Apply at Grants.gov by February 26

HRSA-14-083  Ryan White HIV/AIDS Program Part B AIDS Drug Assistance
Apply at Grants.gov by February 26

 


 

Press Releases

 

 

 

 

 

Program Update

340B Drug Pricing Program

Important Benefit, Significant Responsibility

The 340B Program, administered by the Health Resources and Services Administration (HRSA), plays an integral role in supporting our health care safety net. These designated hospitals, clinics and other providers work with very limited resources to confront the most intractable health problems facing millions of Americans. The 340B Program helps these health care providers stretch scarce federal resources by allowing eligible entities to purchase drugs for outpatient use at a significant discount. Studies show that entities participating in the 340B Program are able to expand the type and volume of care they provide to the most vulnerable patient populations as a result of access to these lower cost medications. The number of providers participating in this program has increased in recent years. The vast majority of these providers (82 percent) dispense these discounted drugs through an in-house pharmacy; a small minority of covered entities (18 percent) contract with pharmacies to dispense these discounted drugs to eligible patients, and of those, 75 percent use fewer than five contract pharmacy arrangements. Read more >>